循环胰岛素样生长因子-1和多发性硬化症风险:一个前性队列研究
Xiao-Wei Pang1, Sheng Yang1, Lu-Yang Zhang1
1Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, Wuhan 430030, PR China.
Multiple sclerosis and related disorders
|January 30, 2025
概括
胰岛素样生长因子1 (IGF-1) 的较低水平与患多发性硬化症 (MS) 的风险降低有关. 这一发现表明IGF-1可能会影响MS的发展.
科学领域:
- 神经学 神经学
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
背景情况:
- 循环胰岛素样生长因子1 (IGF-1) 与中风,阿尔茨海默氏症和帕金森病的风险增加有关.
- IGF-1与多发性硬化症 (MS) 风险之间的关系尚不清楚.
研究的目的:
- 研究循环IGF-1水平与患MS的风险之间的关联.
主要方法:
- 来自英国生物银行的348,324名参与者的前性研究.
- 考克斯的比例危险模型被用来分析IGF-1和MS风险之间的关联.
- 进行了子组分析,以确定影响因素.
主要成果:
- 循环中的IGF-1度较低与MS风险降低有关 (95% CI,0.5930-0.9700;P=0.02763).
- 这种关联在老年人和女性参与者中是一致的.
- 在IGF-1水平较低,从未吸烟,目前饮酒,BMI较高和葡萄糖水平较高的人群中观察到MS风险降低.
结论:
- 低血清IGF-1度与MS风险降低有关.
- 循环IGF-1可能在MS的发病过程中发挥作用.
相关概念视频
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...


